Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Baxter
Queensland Health
Farmers Insurance
US Army
Accenture
Boehringer Ingelheim
Cantor Fitzgerald
McKinsey

Generated: April 21, 2018

DrugPatentWatch Database Preview

Rp Scherer Company Profile

« Back to Dashboard

What is the competitive landscape for RP SCHERER, and what generic and branded alternatives to RP SCHERER drugs are available?

RP SCHERER has one approved drug.



Summary for Rp Scherer
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Rp Scherer

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rp Scherer PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078703-002 Jul 15, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Rp Scherer PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078703-004 Jul 15, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Rp Scherer PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078703-001 Jul 15, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Rp Scherer PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078703-003 Jul 15, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Teva
US Department of Justice
McKinsey
Harvard Business School
Healthtrust
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.